Serum albumin level is associated with mortality and hospital stays: A real-world data analysis

被引:0
|
作者
Yang, Chao [1 ]
Lu, Juntao [2 ]
Shen, Fang [1 ]
Xie, Hua [3 ]
Cui, Hongyuan [4 ]
Xu, Renying [5 ]
机构
[1] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Biliary Pancreat Surg, Sch Med, Shanghai 200127, Peoples R China
[2] Shanghai Jiao Tong Univ, Ren Ji Hosp, Dept Digest, Sch Med, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Clin Nutr, Sch Med, Shanghai 200050, Peoples R China
[4] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Natl Ctr Gerontol,Dept Gen Surg, Beijing 100730, Peoples R China
[5] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Clin Nutr, Shanghai 200127, Peoples R China
关键词
Cancer; Hypoalbuminemia; Length of hospital stays (LOS); Mortality; KIDNEY-DISEASE; MALNUTRITION; MORBIDITY;
D O I
10.1016/j.clnesp.2024.10.002
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: The value of serum albumin might be underestimated, especially in cancer patients. We thus aimed to evaluate the association between serum albumin level at hospital admission and clinical outcomes in hospitalized patients with cancer. Methods: This is a retrospective, cross-sectional, and real-world data analysis. Hospitalized adult patients with malignant cancer were recruited from two tertiary hospitals. Serum level of albumin, which was measured within 24 h after hospital admission, was the exposure. Length of hospital stays (LOS) was the primary and all-cause in-hospital mortality was the secondary outcomes. Other information, including age, sex, types of cancer, history of hypertension and diabetes, surgery, blood routine test, liver and renal function, and dietary intake, were also abstracted from medical records. Results: A total number of 5187 adult patients with cancer (2949 were men and 2238 women; average age 61.6 +/- 12.4 years and average albumin 40.3 +/- 5.2 g/L) were included. The prevalence of hypoalbuminemia was 12.2 % (634/5187). Older patients, patients with liver injury, anemia, and with high level of WBC were positively, while those with overweight and high level of total triglycerides, were negatively associated with hypoalbuminemia. After adjustment of covariates, hypoalbuminemia was significantly associated with longer LOS in the current study. The increase of 5 g/L in serum level of albumin could result in 1.09 days (95%CI: -1.38, -0.80 days) shorter in LOS. The increase of 5 g/L in serum level of albumin was also associated with 45 % lower in risk of mortality (OR = 0.55; 95% CI: 0.43, 0.7) after fully adjustment. Conclusions: Serum albumin level at admission was associated with both LOS and mortality in patients with malignant cancer. (c) 2024 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 50 条
  • [1] Real-World Data Analysis of Pregnancy-Associated Breast Cancer at a Tertiary-Level Hospital in Romania
    Simionescu, Anca A.
    Horobet, Alexandra
    Belascu, Lucian
    Median, Dragos Mircea
    MEDICINA-LITHUANIA, 2020, 56 (10): : 1 - 13
  • [2] Identifying new safety risk of human serum albumin: a retrospective study of real-world data
    Lu, Hui
    Zhang, Yuwei
    Liu, Pengcheng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] REAL-WORLD DISEASE BURDEN AND MORTALITY ASSOCIATED WITH BRONCHIECTASIS
    Feliciano, Joseph
    Wassel, Christina
    Feld, Alexandra
    Maynard, Jason
    Batchu, Lakshmi
    Lauterio, Melanie
    Mohanty, Maitreyee
    Dasenbrook, Elliott
    CHEST, 2023, 164 (04) : 4944A - 4945A
  • [4] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [5] Fourier analysis of real-world data
    Johnson, ML
    Straume, M
    ULTRASENSITIVE BIOCHEMICAL DIAGNOSTICS II, PROCEEDINGS OF, 1997, 2985 : 237 - 246
  • [6] Bivalirudin is not associated with lower in-hospital mortality than heparin in real-world primary PCI
    Hasun, M.
    Doerler, J.
    Jirak, P.
    Wegner, C.
    Grimm, G.
    Siostrzonek, P.
    von Lewinski, D.
    Roithinger, F. X.
    Benzer, W.
    Eber, B.
    Mayr, Harald
    Alber, H.
    Weidinger, F.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S8 - S9
  • [7] Bivalirudin is not associated with lower in-hospital mortality than heparin in real-world primary PCI
    Hasun, M.
    Doerler, J.
    Jirak, P.
    Wegner, C.
    Grimm, G.
    Siostrzonek, P.
    von Lewinski, D.
    Roithinger, F. X.
    Benzer, W.
    Eber, B.
    Mayr, Harald
    Alber, H.
    Weidinger, F.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S8 - S9
  • [8] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [9] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [10] ANALYSIS OF REAL-WORLD EVIDENCE AND REAL-WORLD DATA BY CONITEC, BRAZILIAN HTA AGENCY
    Nita, M. E.
    Riveros, B. S.
    Vaz, P.
    Mussolino, F.
    VALUE IN HEALTH, 2016, 19 (03) : A286 - A286